If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
First CINOD Meets all Three Co-primary Endpoints (p…
Biopharmaceuticals
NicOx, naproxcinod, CINOD
Posts from ‘November, 2008’
Third Pivotal Phase 3 Study for NicOx’ Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
Johnson and Johnson Announces Definitive Agreement to Acquire Omrix
Omrix’s Biopharmaceutical Expertise Complements ETHICON’s Industry-Leading Surgery Portfolio
NEW BRUNSWICK, N.J. and NEW YORK, Nov. 24 (HSMN NewsFeed) — Johnson & Johnson (NYSE: JNJ ) and Omrix Biopharmaceuticals, Inc. (Nasdaq: OMRI ), a fully integr…
Biopharmaceuticals, Acquisitions
Johnson & Johnson, Omrix Biopharmaceuticals
ATS Medical Announces First Commercial Implants of the ATS 3f Aortic Bioprosthesis in the United States
MINNEAPOLIS, Nov. 24 (HSMN NewsFeed) — ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced that the first three commercial implants of the ATS 3f® Aortic Bioprosthes…
Devices, Cardiology
ATS Medical, ATS 3f, Aortic Bioprosthesis, aortic tissue valve
Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival In Advanced Breast Cancer
First Phase III Study (RIBBON 1) To Show Avastin’s PFS Benefit With Capecitabine, As Well As With Anthracycline-Based Chemotherapies
South San Francisco, Calif. - November 23, 2008 - (HSMN NewsFeed) - Genentech, Inc. (NYSE:DNA) today announced that a Ph…
Biopharmaceuticals, Oncology
Genentech, RIBBON 1, Avastin, bevacizumab, breast cancer
Given Imaging Announces French Health Ministry Finalizes Reimbursement for PillCam SB
64 Million French Citizens Now Have Reimbursed Access to Non-Invasive Tool for Diagnosing Small Bowel Disease
YOQNEAM, ISRAEL–Nov 21, 2008 — Given Imaging Ltd. (NasdaqGM:GIVN ) today announced that the French Ministry of Health has concluded the reimb…
Devices, Gastroenterology, Reimbursement
Given Imaging, PillCam, capsule endoscopy
CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
Not for UK Journalists
MAIDENHEAD, England, November 21 (HSMN NewsFeed) — The European Committee for Medicinal Products for Human Use (CHMP) today announced its positive recommendation for the approval of Enbrel® (etanercept) as a treatment for c…
Biopharmaceuticals, Regulatory
Wyeth Pharmaceuticals, Enbrel, etanercept, psoriasis
Lilly Completes Cash Tender Offer for ImClone Systems
INDIANAPOLIS and New York, Nov. 21 (HSMN NewsFeed) — Eli Lilly and Company (NYSE: LLY ) and ImClone Systems Incorporated (Nasdaq: IMCL ) today announced the successful completion of the previously announced tender offer by Lilly’s wholly-owned subsidiar…
Biopharmaceuticals, Mergers & Acquisitions
Eli Lilly, ImClone Systems
SonoSite Awarded Portable Ultrasound Contract with HealthTrust Purchasing Group
BOTHELL, WA - November 21, 2008 - (HSMN NewsFeed) - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound at the point-of-care, today announced that HealthTrust Purchasing Group has awarded SonoSite a contract for portabl…
Devices, Group Purchasing
SonoSite, HealthTrust Purchasing Group, M-Turbo, S Series, MicroMaxx
Tengion Announces Second Closing of Series C Financing
Funds to Support Medical Trials for Tengion Neo-Bladder(TM) Franchise EAST NORRITON, Pa., Nov. Nineteen (HSMN NewsFeed) — Tengion Inc., a clinical stage regenerative medicine company focused on the development of neo-organs and neo-tissues, today announce…
Regenerative Medicine, Venture Capital
Tengion, Neo-Bladder
Impax Sued Based on Anda for Generic Cymbalta(R)
HAYWARD, Calif. November 18, 2008–(HSMN NewsFeed)–IMPAX Laboratories, Inc. today announced Eli Lilly and Company has filed suit alleging infringement U.S. Patent No. 5,023,269 (the "’269 patent") in the United States District Court for the Sout…
Biopharmaceuticals, Generics, Litigation
IMPAX Laboratories, Eli Lilly, duloxetine, Cymbalta
